How many institutions held TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in Q2 2022?

81 institutional investors reported TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value for Q2 2022. Use the holders table for investor-level position and value details.

TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Q: What does CUSIP 89455T109 represent in this 13F holders report?

CUSIP 89455T109 is the security identifier for TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 89455T109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common stock, $0.001 par value
Shares outstanding: 64,609,137
Total 13F shares: 23,108,213
Share change: +2,758,379
Total reported value: $331,376,313
Put/Call ratio: 0%
Price per share: $14.34
Number of holders: 81
Value change: +$38,889,452
Number of buys: 49
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 89455T109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ALLIANCEBERNSTEIN L.P.	13F	Company	4.9%	3,158,645	$59,730,000	—	31 Mar 2022	13F
John R. Treace	3/4/5	Director	— class O/S missing	2,231,606	$59,159,875	—	09 May 2022	3/4/5
VANGUARD GROUP INC	13F	Company	3.7%	2,370,382	$44,824,000	—	31 Mar 2022	13F
NEXT CENTURY GROWTH INVESTORS LLC	13F	Company	2.6%	1,687,850	$31,917,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	2.5%	1,605,189	$30,352,000	—	31 Mar 2022	13F
CIBC Private Wealth Group LLC	13F	Company	1.7%	1,129,709	$21,363,000	—	31 Mar 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.5%	971,192	$18,365,000	—	31 Mar 2022	13F
TimesSquare Capital Management, LLC	13F	Company	1.4%	873,324	$16,515,000	—	31 Mar 2022	13F
EMERALD ADVISERS, LLC	13F	Company	1.4%	872,279	$16,495,000	—	31 Mar 2022	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	1.1%	723,196	$13,676,000	—	31 Mar 2022	13F
Joe W. Ferguson	3/4/5	SVP, Research & Development	— mixed-class rows	754,325 mixed-class rows	$13,396,325	—	06 Oct 2021	3/4/5
JANUS HENDERSON GROUP PLC	13F	Company	1%	666,412	$12,601,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.96%	622,293	$11,768,000	—	31 Mar 2022	13F
Novo Holdings A/S	13F	Company	0.77%	500,421	$9,463,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.75%	486,776	$9,205,000	—	31 Mar 2022	13F
LORD, ABBETT & CO. LLC	13F	Company	0.72%	464,531	$8,784,000	—	31 Mar 2022	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.7%	451,835	$8,544,000	—	31 Mar 2022	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.69%	444,785	$8,411,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.64%	412,611	$7,803,000	—	31 Mar 2022	13F
Jaime A. Frias	3/4/5	Chief Legal Officer	— mixed-class rows	337,008 mixed-class rows	$7,322,274	—	08 Mar 2022	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.56%	361,579	$6,837,000	—	31 Mar 2022	13F
Roubaix Capital, LLC	13F	Company	0.4%	257,308	$4,866,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.37%	238,041	$4,501,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.36%	235,173	$4,448,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.33%	211,760	$4,004,000	—	31 Mar 2022	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.33%	211,024	$3,990,000	—	31 Mar 2022	13F
STIFEL FINANCIAL CORP	13F	Company	0.2%	130,538	$2,468,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	125,721	$2,378,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.17%	109,619	$2,157,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.16%	106,205	$2,008,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.16%	105,316	$1,992,000	—	31 Mar 2022	13F
Dakota Wealth Management	13F	Company	0.13%	85,574	$1,618,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	0.13%	85,000	$1,607,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.12%	77,652	$1,468,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.09%	60,718	$1,149,000	—	31 Mar 2022	13F
Man Group plc	13F	Company	0.06%	40,058	$757,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.06%	37,700	$713,000	—	31 Mar 2022	13F
CNA FINANCIAL CORP	13F	Company	0.04%	28,904	$547,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	28,739	$543,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	28,115	$531,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	26,405	$499,000	—	31 Mar 2022	13F
Trexquant Investment LP	13F	Company	0.04%	24,780	$469,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.04%	24,374	$461,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.03%	20,282	$384,000	—	31 Mar 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.03%	20,109	$380,000	—	31 Mar 2022	13F
MetLife Investment Management, LLC	13F	Company	0.03%	19,037	$359,990	—	31 Mar 2022	13F
TWINBEECH CAPITAL LP	13F	Company	0.03%	17,831	$337,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	17,295	$327,000	—	31 Mar 2022	13F
DUPONT CAPITAL MANAGEMENT CORP	13F	Company	0.03%	16,822	$318,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.02%	15,781	$298,000	—	31 Mar 2022	13F

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2022

As of 30 Jun 2022, TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,108,213 shares. The largest 10 holders included ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, BlackRock Inc., NEXT CENTURY GROWTH INVESTORS LLC, CIBC Private Wealth Group, LLC, EMERALD ADVISERS, LLC, PERCEPTIVE ADVISORS LLC, EMERALD MUTUAL FUND ADVISERS TRUST, TimesSquare Capital Management, LLC, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.